Self-administration of Subcutaneous Bimekizumab Proves Safe,

Self-administration of Subcutaneous Bimekizumab Proves Safe, Effective in PsA

Self-injection of bimekizumab was generally well tolerated among patients with psoriatic arthritis.

Related Keywords

Alan Kivitz , Clinical Research Alan Kivitz , Clinical Research , Altoona Center , Patient Preference , Pain Visual Analog Scale , Self Injection Assessment Questionnaire ,